DAVID GLENN (Chief Financial Officer) received a stock award from PHIBRO ANIMAL HEALTH CORP
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/19/2025ACC: 0001104659-25-080272
Officer· Chief Financial Officer
Since Feb 2026
+4.84K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
4.84K acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+4.84K
Price / share
—
Trade value
—
% of position
16.2%
8/15/2025
30K→34.84K
Total
Net shares
+4.84K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 8/15/2025 | A · Award | +4.84K | — | — | 16.2% | 30K | 34.84K |
| Total | +4.84K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported